GRACE-trial: a randomised active-controlled trial for vulvovaginal atrophy in patients with breast cancer on endocrine therapy - study protocol.

Vergauwen G, Cools P, Denys H, Fiers T, Van de Vijver K, Veldeman L, Verstraelen H

Open source

DOI
10.1136/bmjopen-2022-068053
Published
2023 Apr 11
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2022-068053,
  title = {GRACE-trial: a randomised active-controlled trial for vulvovaginal atrophy in patients with breast cancer on endocrine therapy - study protocol.},
  author = {Vergauwen G and Cools P and Denys H and Fiers T and Van de Vijver K and Veldeman L and Verstraelen H},
  year = {2023},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2022-068053},
  url = {https://doi.org/10.1136/bmjopen-2022-068053}
}

RIS

TY  - JOUR
TI  - GRACE-trial: a randomised active-controlled trial for vulvovaginal atrophy in patients with breast cancer on endocrine therapy - study protocol.
AU  - Vergauwen G
AU  - Cools P
AU  - Denys H
AU  - Fiers T
AU  - Van de Vijver K
AU  - Veldeman L
AU  - Verstraelen H
PY  - 2023
JO  - BMJ open
DO  - 10.1136/bmjopen-2022-068053
UR  - https://doi.org/10.1136/bmjopen-2022-068053
ER  - 

APA

G, V., P, C., H, D., T, F., K, V. D. V., L, V., & H, V. (2023). GRACE-trial: a randomised active-controlled trial for vulvovaginal atrophy in patients with breast cancer on endocrine therapy - study protocol.. BMJ open. https://doi.org/10.1136/bmjopen-2022-068053

Source records